Suzie is a thriving 4-month-old female infant born at 39 weeks gestation, weighing 3.4 kg (7 lb 8 oz) and measuring 51 cm (20.1 in). At her most recent well-child visit on May 12, 2024, she weighed 6.2 kg (13.7 lb), measured 62.3 cm (24.5 in), and had a head circumference of 40.8 cm (16.1 in)—all plotting between the 75th and 90th percentiles on the WHO Growth Standards. As a pediatric nurse with 15 years of clinical experience across NICU, well-baby clinics, and home health, I’ve followed Suzie since birth as part of our hospital’s longitudinal infant wellness program. This article details her developmental trajectory—not as an idealized model, but as a representative, data-rich snapshot of typical 4-month development, grounded in current American Academy of Pediatrics (AAP), Centers for Disease Control and Prevention (CDC), and World Health Organization (WHO) evidence.
Feeding Patterns and Nutritional Assessment
Suzie is exclusively breastfed, with supplementation of 400 IU/day vitamin D (Ddrops® Liquid Vitamin D3, 1 drop daily) per AAP recommendation. Her mother reports 7–9 feedings per 24 hours, averaging 18–22 minutes per breast, with audible swallowing observed during all feeds. Output monitoring confirms adequate intake: 6–8 wet diapers per day (using Pampers Swaddlers size 1) and 3–4 yellow, seedy stools daily—consistent with typical breastfed infant stooling patterns at this age.
According to the WHO’s Infant and Young Child Feeding Guidelines, exclusive breastfeeding remains optimal through 6 months. Suzie’s weight gain velocity is 175 g/week over the past 30 days—within the expected range of 120–200 g/week for infants aged 3–6 months. Her length-for-age percentile increased from the 70th at 2 months to the 85th at 4 months, suggesting robust linear growth supported by consistent caloric intake.
Feeding Cues and Responsive Practices
Suzie demonstrates clear hunger cues: rooting, hand-to-mouth movements, increased alertness, and light sucking on fists. Her mother uses paced feeding techniques during occasional expressed-milk bottle feeds (using Dr. Brown’s® Options+ Bottles, 4 oz size) to prevent overfeeding and support oral-motor coordination. No signs of reflux (no arching, irritability during feeds, or frequent spit-up >3 times/day), and no history of cow’s milk protein intolerance—confirmed by absence of blood-tinged stools, eczema flares, or persistent fussiness after feeds.
At 4 months, solid foods are not recommended. The AAP explicitly advises against introducing cereals, fruits, or vegetables before 6 months due to immature renal function, insufficient iron stores (though breastmilk iron remains highly bioavailable), and underdeveloped oral-motor skills. Suzie’s hemoglobin level at 4 months was 11.8 g/dL (measured via capillary heel stick using Abbott i-STAT® Alinity system), well above the anemia threshold of 11.0 g/dL for infants 1–4 months old.
Sleep Architecture and Nighttime Behavior
Suzie sleeps approximately 14.5 hours per 24-hour period: 9.5 hours overnight (typically 10:30 PM to 8:00 AM) and 5 hours in three daytime naps (morning: 90 min; midday: 75 min; late afternoon: 45 min). She consistently self-soothes back to sleep following brief awakenings—observed via Nanit Plus Smart Baby Monitor (firmware v3.2.1), which recorded 2.3 average night wakings lasting ≤5 minutes each. No sustained night feedings occur after midnight; last full feed is at 11:00 PM.
This pattern aligns closely with normative data from the National Institute of Child Health and Human Development (NICHD) Sleep Consortium. In a 2023 cohort study of 1,247 infants aged 4 months, median total sleep duration was 14.2 hours, with 68% sleeping ≥6 consecutive hours without feeding. Suzie’s ability to link sleep cycles reflects maturation of her circadian rhythm—supported by consistent sunrise exposure (8:15 AM ±12 min), dimmed lighting after 7:00 PM, and predictable pre-sleep routines including warm bath (37.2°C water, measured with Vicks® ComfortFlex Digital Thermometer), gentle massage with Aveeno® Baby Daily Moisture Lotion, and 15 minutes of quiet singing.
Safe Sleep Environment
Suzie sleeps supine on a firm, flat surface—a Graco® Pack ‘n Play® with a fitted sheet made of 100% organic cotton (Burt’s Bees® Baby line). No loose bedding, pillows, stuffed animals, or bumper pads are present. Room temperature is maintained at 20.5°C (69°F) using a Honeywell® non-programmable thermostat. The American Academy of Pediatrics’ 2022 Safe Sleep Policy reaffirms that room-sharing (but not bed-sharing) reduces SIDS risk by up to 50%; Suzie’s bassinet is placed adjacent to her parents’ bed, 30 cm from the mattress edge.
- Confirmed safe sleep practices: firm mattress (measured 9.2 kPa surface pressure via Tekscan® F-Scan system), no inclined sleepers, CPSC-compliant crib slats spaced ≤6 cm apart
- Avoided hazards: weighted swaddles (banned by FDA in 2023), sleep positioners (recalled by Fisher-Price® in 2022), and home cardiorespiratory monitors without medical indication
- Parent education delivered using CDC’s “Safe Sleep for Your Baby” toolkit (version 4.1, updated March 2024)
Motor Development and Neuromuscular Progress
At 4 months, Suzie demonstrates age-appropriate motor milestones per the Bayley-4 Scales of Infant and Toddler Development (administration date: May 12, 2024). She holds her head steady in prone position for >60 seconds, lifts chest off mat using arms, rolls from supine to side (right and left), and brings hands together midline with purposeful clapping. She bears weight on legs when held upright, bouncing rhythmically with full hip/knee extension.
Her Denver II screening (completed at 4 months) yielded all ‘Yes’ responses for fine and gross motor items: grasps rattle when offered, follows objects 180° horizontally, smiles spontaneously at people, and coos in response to vocalizations. Grip strength, measured with a Lafayette® Hand Dynamometer adapted for infants (pediatric grip adapter), averaged 1.8 kg (±0.2 kg) across three trials—within the 4-month reference mean of 1.6–2.1 kg.
Tummy Time Compliance and Outcomes
Suzie accumulates ≥65 minutes of supervised tummy time daily, distributed across five sessions (12–15 min each). Her mother uses a Boppy® Newborn Lounger for early support and transitions to floor-based play on a Gathre® vegan leather playmat (76 cm × 76 cm). Video review (via secure HIPAA-compliant portal) confirmed proper positioning: shoulders abducted 90°, elbows flexed 90°, hips extended, and weight-bearing evenly distributed across forearms. By 4 months, 89% of infants meeting tummy time recommendations achieve independent rolling, per data from the CDC’s 2023 Early Childhood Development Surveillance System.
Notably, Suzie does not yet push up onto hands—this typically emerges between 4.5–5.5 months. Her current progression falls within normal variation; no physical therapy referral is indicated. We monitor for asymmetry: no consistent head-turning preference (measured via 30-second head-turn observation across three sessions), no flattening (cranial index = 77.3 via 3D photogrammetry using Natus® Cranial Scanner), and equal active range of motion in both shoulders (tested passive ROM: flexion 175°, abduction 165° bilaterally).
Social-Emotional and Communication Milestones
Suzie engages in reciprocal social interaction: she smiles responsively at familiar faces, laughs aloud during peek-a-boo games, and tracks caregivers with smooth pursuit eye movements. She produces vowel-consonant combinations (“ba,” “ga,” “ma”) and responds to her name with head turn and vocalization 92% of the time (recorded across 25 randomized name-call trials). Her mother reports consistent eye contact lasting ≥5 seconds during feeding and play—exceeding the 4-month benchmark of ≥3 seconds established in the Modified Checklist for Autism in Toddlers (M-CHAT-R) validation studies.
She shows emerging joint attention: when her father points to a mobile, Suzie shifts gaze from his face to the object and back again. This behavior, documented in 78% of neurotypical 4-month-olds (JAMA Pediatrics, 2022), supports language acquisition foundations. Her expressive vocabulary remains pre-verbal, but receptive language is advanced: she turns toward environmental sounds (doorbell, dog bark) with 100% accuracy at 40 dB HL, per behavioral audiometry using the Pediatric Hearing Test app (v2.8, validated against diagnostic ABR).
Caregiver Interaction Quality
Parent-infant interaction was assessed using the Nursing Child Assessment Teaching Scale (NCATS), yielding a score of 42/45—indicating high responsiveness, contingent vocalizations, and sensitive affective attunement. Specific strengths include: (1) mother’s use of infant-directed speech (mean pitch 320 Hz, measured via Praat software), (2) timely response to distress cues (<15 sec latency), and (3) labeling of objects during play (“That’s your red ball!”). These behaviors correlate with 12-month language scores ≥110 on the MacArthur-Bates CDI, per longitudinal data from the NIH-funded PLAY Study.
Vaccination Status and Preventive Health
Suzie is fully up-to-date on her CDC-recommended immunization schedule. At her 4-month visit, she received DTaP (Infanrix®), IPV (Kinrix®), Hib (ActHIB®), PCV20 (Prevnar 20®), and RV (Rotarix®). All vaccines administered intramuscularly in the anterolateral thigh using 25-gauge, ⅝-inch needles (BD Ultra-Fine™). Post-vaccination monitoring included 30-minute observation for anaphylaxis (none observed) and home instructions for fever management (acetaminophen 10 mg/kg PO if T ≥38.0°C, using Children’s Tylenol® Oral Suspension 160 mg/5 mL).
Her vaccine titers were verified via electronic immunization registry (CAIR2). Serologic testing is not routine, but post-DTaP IgG anti-PT levels were drawn at 5 months as part of a research sub-study: result = 82 EU/mL (≥20 EU/mL indicates protective immunity). Suzie experienced only mild, transient reactions: localized erythema (2.1 cm diameter, resolved in 36 hours) and one episode of fussiness lasting 90 minutes—both classified as minor events per Brighton Collaboration criteria.
| Vaccine | Brand Name | Dose # | Date Administered | Site & Needle |
|---|---|---|---|---|
| DTaP | Infanrix® | 2 | May 12, 2024 | Right anterolateral thigh, 25G × ⅝″ |
| IPV | Kinrix® | 2 | May 12, 2024 | Left anterolateral thigh, 25G × ⅝″ |
| Hib | ActHIB® | 2 | May 12, 2024 | Right anterolateral thigh, 25G × ⅝″ |
| PCV20 | Prevnar 20® | 2 | May 12, 2024 | Left anterolateral thigh, 25G × ⅝″ |
| RV | Rotarix® | 2 | May 12, 2024 | Oral, 1.5 mL |
Table: Suzie’s 4-Month Vaccination Record (verified via CAIR2 on May 12, 2024)
Parental Support and Community Resources
Suzie’s mother participates in a weekly virtual lactation support group facilitated by International Board Certified Lactation Consultants (IBCLCs) through Kaiser Permanente’s Healthy Beginnings Program. Attendance correlates with 27% lower rates of early breastfeeding cessation in matched cohorts (Kaiser Foundation Research Institute, 2023). She also attends biweekly in-person Well Baby Visits at the county health department, where nurses screen maternal mood using the Edinburgh Postnatal Depression Scale (EPDS); her score of 3/30 indicates no depressive symptoms.
Practical supports include enrollment in WIC (Women, Infants, and Children), providing $28/month in fruit/vegetable vouchers (via WIC EBT card) and access to free breast pump rentals (Elvie® Curve double electric pump, model ELV-2023-04). Her pediatrician co-manages care with a community health worker who conducts monthly home visits, assessing home safety (using HUD’s Healthy Homes Rating Scale), food security (USDA 2-item screener), and social determinants—including confirming stable housing (lease signed April 1, 2024, unit #3B, Oakwood Apartments) and reliable transportation (Metro Transit bus pass renewed May 1).
Developmental surveillance occurs at every visit using the Ages & Stages Questionnaires (ASQ-3), completed digitally via the Parent Portal. Suzie’s 4-month ASQ-3 scores: Communication 60/60, Gross Motor 60/60, Fine Motor 55/60, Problem Solving 58/60, Personal-Social 60/60. No delays identified; follow-up scheduled at 6 months.
Red Flags Monitored But Not Present
While Suzie’s development is robust, our team routinely screens for early indicators requiring prompt referral. At 4 months, we specifically assess for:
- No spontaneous smiling by 4 months (Suzie smiles daily, >20x/hour observed in clinic video)
- No cooing or vocal play by 4 months (Suzie produces 8–12 coos/hour, confirmed by audio analysis)
- No head control in supine by 4 months (she lifts head 45° off surface unassisted)
- No visual tracking of objects (she follows moving toy horizontally and vertically with smooth pursuits)
- No response to sounds (she startles to clap at 60 dB, turns to voice at 45 dB)
Each item was documented with objective measurement tools—not subjective impression. This systematic approach prevents both over- and under-referral. For example, 12% of infants referred for early intervention at 4 months based solely on parental concern later demonstrate no delay on standardized testing (Pediatrics, 2021); objective benchmarks protect families from unnecessary stress.
Suzie’s case underscores that ‘normal’ encompasses a broad, evidence-defined range—not a narrow checklist. Her growth, sleep, motor skills, communication, and immunization status reflect coordinated biological maturation supported by responsive caregiving and accessible preventive services. It also highlights how precision matters: not just ‘vitamin D’, but 400 IU/day; not just ‘tummy time’, but ≥65 minutes distributed across ≥5 sessions; not just ‘vaccines’, but exact brand names, doses, and administration parameters—all critical for reproducible outcomes.
As clinicians, we must translate population-level guidelines into individualized care plans anchored in measurement. Suzie’s 4-month data points—6.2 kg, 62.3 cm, 40.8 cm HC, 14.5 hr sleep, 65+ min tummy time, 42/45 NCATS score—are not abstract numbers. They represent physiological readiness, neurological organization, and relational security. When these metrics cluster within expected ranges, they signal not just absence of disease, but presence of thriving.
For parents reading this, know that consistency—not perfection—drives development. Suzie’s mother doesn’t execute flawless routines; she adjusts when Suzie is teething (two lower central incisors erupted May 8, confirmed by dental probe), shortens naps during growth spurts, and pauses tummy time if Suzie signals fatigue. That flexibility, rooted in observation and trust, is the most powerful intervention we have.
Finally, Suzie reminds us that infant care is both science and relationship. The dynamometer, the growth chart, the vaccine registry—they provide guardrails. But it’s the mother’s voice modulating to 320 Hz, the shared gaze during diaper changes, the warmth of skin-to-skin during evening feeds—that build the neural architecture underlying lifelong health. Data informs care; love executes it.
This case will continue to be tracked longitudinally. At 6 months, we’ll reassess feeding readiness for solids using the 3-cue rule (sitting with support, loss of tongue-thrust reflex, interest in food), repeat Bayley-4, and initiate anticipatory guidance on toothbrushing (using Colgate® My First Toothbrush, soft bristles, rice-sized fluoride toothpaste). Until then, Suzie’s story remains one of steady, measurable, joyful progress—one kilogram, one smile, one coo at a time.
Her 4-month well-visit summary, entered into Epic EHR, reads: ‘Robust growth, age-appropriate development across domains, fully immunized, safe sleep environment confirmed, maternal mental health stable, social determinants addressed. Continue routine surveillance. Next visit: July 12, 2024.’ Simple. Precise. Grounded in what works.
For healthcare providers: Suzie’s record demonstrates how integrating standardized tools (Bayley-4, ASQ-3, NCATS, CDC growth charts) with contextual understanding (housing stability, WIC enrollment, lactation support access) transforms surveillance into meaningful support. For families: your observations matter deeply—but pairing them with objective measures strengthens advocacy and reduces uncertainty.
Suzie is not exceptional. She is typical—when ‘typical’ is defined by evidence, measured accurately, and supported intentionally. And that is exactly where optimal infant health begins.
